Literature DB >> 11097748

Signalling to translational activation of tumour necrosis factor-alpha expression in human THP-1 cells.

K Andersson1, R Sundler.   

Abstract

Monocytic THP-1 cells expressed tumour necrosis factor-alpha (TNF-alpha) mRNA, but hardly any detectable TNF-alpha protein and a partially activated MAP kinase ERK-2 in the unstimulated state. Stimulation with phorbol ester led to expression of TNF-alpha protein without significant changes in mRNA, a response that was sensitive to the MEK-1/2 inhibitors PD98059 and U0126. A calcium signal also led to expression of TNF-alpha protein, but now accompanied by a rapid increase in mRNA. A synergistic effect between phorbol ester and calcium ionophore was evident at the level of TNF-alpha protein, but not its mRNA. Stimulation with anisomycin led to a TNF-alpha expression that was sensitive to the p38 inhibitor SB203580. Actinomycin D lowered TNF-alpha mRNA in a similar way as PD98059 but was less inhibitory on PMA- or anisomycin-induced formation of TNF-alpha, thus confirming that these agents acted by causing translational derepression. Thus, in THP-1 cells MAP kinase pathways involving MEK-1/2 and possibly ERK-2 as well as the human p38 analogue were essential for basal TNF-alpha mRNA expression and translational activation. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11097748     DOI: 10.1006/cyto.2000.0784

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  9 in total

1.  The effects of cardamonin on lipopolysaccharide-induced inflammatory protein production and MAP kinase and NFkappaB signalling pathways in monocytes/macrophages.

Authors:  S Hatziieremia; A I Gray; V A Ferro; A Paul; R Plevin
Journal:  Br J Pharmacol       Date:  2006-08-07       Impact factor: 8.739

2.  Schisantherin A exhibits anti-inflammatory properties by down-regulating NF-kappaB and MAPK signaling pathways in lipopolysaccharide-treated RAW 264.7 cells.

Authors:  Xinxin Ci; Rong Ren; Kan Xu; Hongyu Li; Qinlei Yu; Yu Song; Dacheng Wang; Rongtao Li; Xuming Deng
Journal:  Inflammation       Date:  2010-04       Impact factor: 4.092

3.  AU-rich-element-mediated upregulation of translation by FXR1 and Argonaute 2.

Authors:  Shobha Vasudevan; Joan A Steitz
Journal:  Cell       Date:  2007-03-23       Impact factor: 41.582

4.  Cryptotanshinone suppressed inflammatory cytokines secretion in RAW264.7 macrophages through inhibition of the NF-κB and MAPK signaling pathways.

Authors:  Shu Tang; Xiao-Yan Shen; He-Qing Huang; Suo-Wen Xu; Yang Yu; Chang-Hua Zhou; Shao-Rui Chen; Kang Le; Yu-Hua Wang; Pei-Qing Liu
Journal:  Inflammation       Date:  2011-04       Impact factor: 4.092

5.  p-Cymene modulates in vitro and in vivo cytokine production by inhibiting MAPK and NF-κB activation.

Authors:  Weiting Zhong; Gefu Chi; Lanxiang Jiang; Lanan Wassy Soromou; Na Chen; Meixia Huo; Weixiao Guo; Xuming Deng; Haihua Feng
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

6.  Rapid and quantitative detection of p38 kinase pathway in mouse blood monocyte.

Authors:  Jingyong Zhao; Glenn Evans; Weiming Li; Lisa Green; Shaoyou Chu; Phil Marder; Songqing Na
Journal:  In Vitro Cell Dev Biol Anim       Date:  2008-04-09       Impact factor: 2.416

7.  RhoA activation participates in rearrangement of processing bodies and release of nucleated AU-rich mRNAs.

Authors:  Shinya Takahashi; Kyoko Sakurai; Arisa Ebihara; Hiroaki Kajiho; Kota Saito; Kenji Kontani; Hiroshi Nishina; Toshiaki Katada
Journal:  Nucleic Acids Res       Date:  2011-01-06       Impact factor: 16.971

8.  The p38/MK2 Axis in Monocytes of Fibromyalgia Syndrome Patients: An Explorative Study.

Authors:  Boya Nugraha; Renate Scheibe; Christoph Korallus; Matthias Gaestel; Christoph Gutenbrunner
Journal:  Medicina (Kaunas)       Date:  2021-04-19       Impact factor: 2.430

9.  Ginsenoside Rh2 Downregulates LPS-Induced NF- κ B Activation through Inhibition of TAK1 Phosphorylation in RAW 264.7 Murine Macrophage.

Authors:  Li-Hua Lian; Quan Jin; Shun-Zong Song; Yan-Ling Wu; Ting Bai; Shuang Jiang; Qian Li; Ning Yang; Ji-Xing Nan
Journal:  Evid Based Complement Alternat Med       Date:  2013-02-17       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.